Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 114 (2) , 223-229
- https://doi.org/10.1016/j.jconrel.2006.05.026
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology (AP 2002-2946, SAF-2002-03686)
- Ministry of Education and Science
This publication has 23 references indexed in Scilit:
- Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivoJournal of Controlled Release, 2005
- Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivoJournal of Biomedical Materials Research Part A, 2005
- Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineeringJournal of Controlled Release, 2004
- Skeletal tissue engineering—from in vitro studies to large animal modelsBiomaterials, 2004
- Transforming growth factor-β1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environmentJournal of Controlled Release, 2003
- rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy modelJournal of Orthopaedic Research, 2003
- In vitro–in vivo characterization of gentamicin bone implantsJournal of Controlled Release, 2002
- In vivo–in vitro study of biodegradable and osteointegrable gentamicin bone implantsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Novel injectable neutral solutions of chitosan form biodegradable gels in situBiomaterials, 2000
- Bone regeneration by transforming growth factor β1 released from a biodegradable hydrogelJournal of Controlled Release, 2000